amobarbital has been researched along with Cephalgia, Vascular in 3 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guthy, H | 1 |
Hildgen, J | 1 |
Brinkmann, G | 1 |
Sabbagh, M | 1 |
Gerbold, H | 1 |
3 other studies available for amobarbital and Cephalgia, Vascular
Article | Year |
---|---|
[Treatment of vascular headache].
Topics: Adult; Amobarbital; Caffeine; Codeine; Ergotamine; Female; Headache; Humans; Male; Middle Aged; Phen | 1969 |
[Therapy of the vasomotor headache in childhood].
Topics: Adolescent; Amines; Amobarbital; Caffeine; Child; Child, Preschool; Codeine; Ergotamine; Headache; H | 1970 |
[Treatment of vascular headaches with a new compound preparation].
Topics: Acetaminophen; Adult; Amobarbital; Analgesics; Caffeine; Codeine; Ergotamine; Female; Headache; Huma | 1970 |